Overall rank by patents
#46,385
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, active 2016–2017. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H02M (APPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER;).
The verdict
Efore holds 5 US patents across 7 technology areas, rank #46,385 of 50,000 tracked assignees.
Efore OYJ has been granted 5 US utility patents between 2016 and 2017, placing Efore OYJ at rank #46,385 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.4 claims per patent with primary concentration in H02M (APPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER;). As a Foreign Corporation, Efore OYJ is one of the more focused assignees in the PatentsView dataset. By volume, Efore sits between Eduard Wille Gmbh & Co. KT (5 patents, rank #46,381) and EHT Ventures Llc (5 patents, rank #46,389) - the closest US assignees by grant volume. The composite Innovation Score of 23.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 5 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Efore OYJ's 12.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Efore OYJ against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EDUARD WILLE GMBH & CO. KT
5 patents
EDWARD VIA VIRGINIA COLLEGE OF OSTEOPATHIC MEDICINE
5 patents
EDX EDUCATION CO., LTD.
5 patents
EFFEKT, LLC
5 patents
EGG-CHICK AUTOMATED TECHNOLOGIES
5 patents
EGGCITING PRODUCTS B.V.
5 patents
EGIS GYOGYSZERGYAR ZRT.
5 patents
EHT Ventures LLC
5 patents
EFORE OYJ
5 patents
What this shows Efore holds 5 patents at rank #46,385, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #46,385 in granted patent volume.
Other assignees with the most granted patents in Efore's primary technology class.
Efore's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 89% higher than 11% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 60.0% |
| 2017 | 2 | 40.0% |
Top 7 of 7 technology areas
Overall rank by patents
#46,385
Across all tracked assignees
23.0 out of 100
How to use this portfolio
Efore's 5 grants land it in the top 89% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.